- Sediment
- Biochemical
- Flow-Cytometric
- Microscopic
Urinalysis Test Market was valued at USD 4065.89 million in 2022 and is anticipated to grow at USD 5937.98 million by 2028 recording a significant CAGR of 5.9% from 2023-2029. Urinalysis (UA) is the analysis of urine or test of your urine. Urinalysis Market is a group of physical, chemical, and microscopic tests. The tests detect and/or measure several substances in the urine, such as byproducts of normal and abnormal metabolism, cells, cellular fragments, and bacteria. Urinalysis is used to detect and manage wide range of disorders as urinary tract infections kidney disease and diabetics. Urinalysis is a urine sample analysis test that aids in the detection of a wide range of illnesses, including diabetes, kidney disease, and urinary tract infection. Its main goal is to keep track of people's health. Urinalysis is performed as part of a general medical check-up, as part of pre-surgery preparation, as part of a pregnancy check-up, or as part of a hospital admission to treat a variety of illnesses. It also aids in the identification of the source of symptoms like back pain, abdominal pain, and uncomfortable urination.
Urinalysis Test Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.3%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Growth
Factors such as growing demand for point-of-care testing, enhance in global geriatric population, new advancement in technology innovation of urinalysis propel the market growth of urinalysis test. Moreover, growth in healthcare expenditure, development of basic medical insurance system in the near future boost the growth of market. However, factors like lack of laboratory staff, High cost associated with advanced urine analyzers, acceptance of fully automated urine analyzers in growing economies is lower and stringent regulatory framework may hamper the growth of the market.
North-America Got Significant Share
Urinalysis Test Market
Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America overwhelmed the general urinalysis test market. The presentation of cutting-edge urinalysis test by entering market players in the U.S., positive government activities guaranteeing the advancement of human services testing, and the high measure of medicinal services spending in this locale are the key components crediting to the biggest piece of the pie of this region. Asia Pacific is relied upon to develop at the most noteworthy CAGR amid the forecast period. Development in this fragment is driven by the components, for example, rising interest for urinalysis test products, expanding medicinal services use, rising pervasiveness of diabetes, and developing geriatric populace are driving the development of the urinalysis test market in this locale.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Urinalysis Test Market Segmentation
Test Type
Application
- UTI
- Diabetes
- Liver Disease
- Kidney
- Pregnancy
End User
- Hospitals
- Diagnostic Labs
- Others
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Hoffmann-La Roche Ltd (Switzerland)
- Dahaner (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- Siemens AG (U.S.)
- ACON Laboratories Inc. (U.S.)
- Sysmex Corporation (Japan)